Tositumomab OverviewTositumomab is a murine monoclonal antibody which targets the CD20 antigen produced in mammalian cell. It was combined with iodine-131 to produce a radiopharmaceutical for unsealed source radiotherapy, Iodine-131 Tositumomab (branded as Bexxar), for the treatment of non-Hodgkins lymphoma. It is classified as a IgG2a lambda antibody. The drug combination was developed by Corixa which was purchased by GlaxoSmithKline in...
Read more Tositumomab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tositumomab
Recent Tositumomab Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 14mg/ml, 20ml
- Vial: 0.1-0.25mg/ml, 1.1-2.5mg/ml, 14mg/ml
Other drugs which contain Tositumomab or a similar ingredient: (1 result)
- BEXXAR Tositumomab